- Home
- ISPC vs ADTX Comparison
ISPC vs ADTX Comparison
Compare ISPC & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- ADTX
- Stock Information
- Founded
- ISPC 2009
- ADTX 2017
- Country
- ISPC United States
- ADTX United States
- Employees
- ISPC N/A
- ADTX N/A
- Industry
- ISPC Precision Instruments
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- ISPC Health Care
- ADTX Health Care
- Exchange
- ISPC Nasdaq
- ADTX Nasdaq
- Market Cap
- ISPC 3.1M
- ADTX 3.1M
- IPO Year
- ISPC 2021
- ADTX 2020
- Fundamental
- Price
- ISPC $1.06
- ADTX $1.20
- Analyst Decision
- ISPC
- ADTX
- Analyst Count
- ISPC 0
- ADTX 0
- Target Price
- ISPC N/A
- ADTX N/A
- AVG Volume (30 Days)
- ISPC 102.3K
- ADTX 2.0M
- Earning Date
- ISPC 08-05-2025
- ADTX 08-18-2025
- Dividend Yield
- ISPC N/A
- ADTX N/A
- EPS Growth
- ISPC N/A
- ADTX N/A
- EPS
- ISPC N/A
- ADTX N/A
- Revenue
- ISPC $8,058,631.00
- ADTX $55,323.00
- Revenue This Year
- ISPC $35.93
- ADTX $15,768.94
- Revenue Next Year
- ISPC N/A
- ADTX N/A
- P/E Ratio
- ISPC N/A
- ADTX N/A
- Revenue Growth
- ISPC N/A
- ADTX N/A
- 52 Week Low
- ISPC $0.86
- ADTX $1.05
- 52 Week High
- ISPC $8.30
- ADTX $21,400.00
- Technical
- Relative Strength Index (RSI)
- ISPC 51.12
- ADTX 39.51
- Support Level
- ISPC $1.01
- ADTX $1.13
- Resistance Level
- ISPC $1.15
- ADTX $1.30
- Average True Range (ATR)
- ISPC 0.12
- ADTX 0.11
- MACD
- ISPC 0.01
- ADTX 0.03
- Stochastic Oscillator
- ISPC 47.06
- ADTX 46.81
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.